Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Current Assets (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Current Assets came in at $6.5 billion in Q2 2026, little changed year-over-year from $6.5 billion in Q2 2025, and up 9.1% quarter-over-quarter from $6.0 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Current Assets across 18 years of filings, most recently posting $6.5 billion for Q2 2026.

  • In Q2 2026, Current Assets changed 0.12% year-over-year to $6.5 billion; the TTM figure through Jun 2026 stood at $6.5 billion (changed 0.12% YoY), while the FY2025 annual figure was $6.2 billion, up 6.63% from the prior year.
  • Current Assets came in at $6.5 billion for Q2 2026 at Bausch Health Companies, up from $6.0 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $6.5 billion in Q2 2026 to a low of $4.0 billion in Q3 2022.
  • Average Current Assets over 5 years is $5.4 billion, with a median of $5.5 billion recorded in 2022.
  • The largest YoY upside for Current Assets was 31.76% in 2023 against a maximum downside of 27.4% in 2023.
  • Over 5 years, Current Assets stood at $4.2 billion in 2022, then jumped by 31.76% to $5.6 billion in 2023, then climbed by 3.18% to $5.8 billion in 2024, then rose by 6.63% to $6.2 billion in 2025, then climbed by 5.93% to $6.5 billion in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $6.5 billion in Q2 2026, $6.0 billion in Q1 2026, and $6.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 13.76 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 10.06 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 3.16 Bn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 1.95 Bn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 6.52 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 544.97 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 825.43 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 630.95 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 72.50 Mn
10 RedHill Biopharma 171.02 Mn 171.02 Mn - 6.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.52 Bn
Mar 31, 2026 5.98 Bn
Dec 31, 2025 6.16 Bn
Sep 30, 2025 6.25 Bn
Jun 30, 2025 6.51 Bn
Mar 31, 2025 5.73 Bn
Dec 31, 2024 5.77 Bn
Sep 30, 2024 5.35 Bn
Jun 30, 2024 5.21 Bn
Mar 31, 2024 5.40 Bn
Dec 31, 2023 5.60 Bn
Sep 30, 2023 5.05 Bn
Jun 30, 2023 4.46 Bn
Mar 31, 2023 4.24 Bn
Dec 31, 2022 4.25 Bn
Sep 30, 2022 4.01 Bn
Jun 30, 2022 5.42 Bn
Mar 31, 2022 5.84 Bn
Dec 31, 2021 5.61 Bn
Sep 30, 2021 5.32 Bn